Atara Bio Announces Proposed Offering of Common Stock
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- AMD shares fall amid AI chip sector selloff
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- JetBlue shares fall amid American results, fuel cost concerns
ATARA Biotherapeutics (ATRA) Boosts Common Stock Shelf Size to $150M
July 9, 2015 10:07 AM EDTATARA Biotherapeutics (Nasdaq: ATRA) filed an amended registration with the U.S. SEC to sell up to $150 million of its Common Stock. The amount is up from a previously registered amount of $125 million.
... MoreAtara Biotherapeutics (ATRA) Announces $125M Common Stock Offering
July 7, 2015 4:06 PM EDTAtara Biotherapeutics (NASDAQ: ATRA) has commenced an underwritten public offering of shares of its common stock and expects to raise gross proceeds of approximately $125.0 million. In addition, Atara Bio expects to grant the underwriters a 30-day option to purchase up to an... More



